Key result
Homozygosity for a common haplotype at the ADIPOR1 locus was associated with a increased risk of coronary artery disease in patients with type 2 diabetes.
Why the study?
Are common haplotypes at the ADIPOR1 locus associated with increased risk of coronary artery disease in patients with type 2 diabetes?
Case-Control (n=944)
Yes
Are common haplotypes at the ADIPOR1 locus associated with increased risk of coronary artery disease in patients with type 2 diabetes?
Genetic variability at the ADIPOR1 locus is a strong determinant of coronary artery disease susceptibility in patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
Does not support ADIPOR1 genotyping for CAD risk assessment in T2D; hypothesis-generating for replication and mechanistic studies.
Adiponectin, an adipokine facilitating insulin action, has antiatherogenic effects. This study investigated whether common polymorphisms in the adiponectin receptor 1 (ADIPOR1) gene mediating these effects influence the risk of coronary artery disease (CAD) in type 2 diabetes. Linkage disequilibrium analysis of 28 single nucleotide polymorphisms (SNPs) spanning the entire ADIPOR1 locus revealed two haplotype blocks that could be tagged by six SNPs. These six markers were typed in two populations of CAD-positive and -negative subjects with type 2 diabetes, one from Boston (n = 411) and the other from Italy (n = 533). In the Boston population, the three tags of the more 3' block were all significantly associated with CAD (P = 0.001-0.01). A similar trend, although not significant, was found in Italian subjects. Haplotype analysis of the combined populations revealed different haplotype distributions in case and control subjects (P = 0.0002), with one common haplotype being associated in homozygotes with a greater than threefold increase in cardiovascular risk (odds ratio 3.6 [95% CI 1.8-7.2]). Some of the genotypes associated with increased cardiovascular risk were associated with 30-40% lower ADIPOR1 mRNA levels in blood mononuclear cells (n = 60) and adipose tissue biopsies (n = 28) (P = 0.001-0.014). Our findings point to genetic variability at the ADIPOR1 locus as a strong determinant of CAD susceptibility in type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Soccio et al. (2006) conducted a case-control in Coronary artery disease in type 2 diabetes (n=944). Common haplotypes at the ADIPOR1 locus vs. Other haplotypes / non-carriers was evaluated on Coronary artery disease (OR 3.6, 95% CI 1.8-7.2, p=0.0002). Homozygosity for a common haplotype at the ADIPOR1 locus was associated with a increased risk of coronary artery disease in patients with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: